TITLE

Letter: Metaclopramide and prolactin

PUB. DATE
August 1974
SOURCE
British Medical Journal;8/10/1974, Vol. 3 Issue 5927, p412
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64111409

 

Related Articles

  • The Effects of Antipsychotics on Prolactin and Bone Mineral Density. BOLU, Abdullah; AY, S. Ahmet // Archives of Neuropsychiatry / Noropsikiatri Arsivi;Jun2015, Vol. 52 Issue 2, p210 

    A letter to the editor is presented in response to the article "The Effects of Prolactin-Raising and Prolactin-Sparing Antipsychotics on Prolactin Levels and Bone Mineral Density in Schizophrenic Patients," by S. Bulut and colleagues in the 2014 issue.

  • A standardized nomenclature for the mouse and rat prolactin superfamilies. Soares, Michael; Alam, S. M.; Duckworth, Mary Lynn; Horseman, Nelson D.; Konno, Toshihiro; Linzer, Daniel I. H.; Maltais, Lois J.; Nilsen-Hamilton, Marit; Shiota, Kunio; Smith, Jennifer R.; Wallis, Michael // Mammalian Genome;Mar2007, Vol. 18 Issue 3, p154 

    A letter to the editor is presented which discusses the significance of the standardized nomenclature for the mouse and rat prolactin superfamilies.

  • Hormonal politics. Weider, Jeff // Contemporary Urology;Sep2003, Vol. 15 Issue 9, p12 

    Presents a letter to the editor in response to the article "Prolactin: An Integral Player in Hormonal Politics," in the May 2003 issue.

  • Polymorphism of the extrapituitary prolactin promoter and systemic sclerosis. Fojtíková, Markéta; Čejková, Pavlína; Bečvář, Radim; Vencovský, Jiří; Studýnková, Jana Tomasová; Černá, Marie // Rheumatology International;Nov2010, Vol. 30 Issue 12, p1691 

    A letter to the editor is presented regarding the high levels of serum prolactin (PRL) in systemic sclerosis (SSc) and polymyositis (PM).

  • Polymorphism of the prolactin extrapituitary promoter in psoriatic arthritis. Štolfa, Jiří; Fojtíková, Markéta; Čejková, Pavlína; Černá, Marie; Šedová, Liliana; Dostál, Ctibor // Rheumatology International;Sep2007, Vol. 27 Issue 11, p1095 

    A letter to the editor is presented about the genetic variation of the prolactin extrapituitary promoter in psoriatic arthritis.

  • Antipsychotics and osteoporosis: current awareness and practice in primary care. Jones, Ernesto // British Journal of General Practice;Nov2014, Vol. 64 Issue 628, p562 

    A letter to the editor is presented regarding the importance for general practitioners (GPs) to check prolactin on patients taking antipsychotics as it might cause osteoporosis.

  • Prolactin response to neuroleptic challenge. Shur, Eric; Checkley, Stuart; Shur, E; Checkley, S // British Journal of Psychiatry;Apr82, Vol. 140, p431 

    A letter to the editor is presented in response to an article about prolactin response to haloperidol in patients with schizophrenia.

  • Exploring functional polymorphisms in the dopamine receptor D2 gene using prolactin concentration in healthy subjects. Fukui, N.; Suzuki, Y.; Sugai, T.; Watanabe, J.; Ono, S.; Tsuneyama, N.; Someya, T. // Molecular Psychiatry;Apr2011, Vol. 16 Issue 4, p356 

    A letter to the editor is presented which discusses the use of prolactin concentration to explore functional polymorphisms in the dopamine receptor D2 gene in healthy individuals.

  • Potential Confounder: Bernard and de Burbure Respond. Bernard, Alfred; de Burbure, Claire // Environmental Health Perspectives;Aug2006, Vol. 114 Issue 8, pA458 

    A response by Alfred Bernard and Claire de Burbure to a letter to the editor about her article, discussing the potential of manganese as confounder of serum prolactin, in the previous issue is presented.

  • Metoclopramide.  // Reactions Weekly;11/1/2008, Issue 1226, p19 

    The article describes the case of a 71-year-old man with Parkinson's disease (PD) who developed encephalopathy after beginning treatment with metaclopramide. After starting metaclopramide, he experienced a marked exacerbation of his motor symptomology, agitation, aggression and changes in...

Share

Read the Article

Other Topics